scholarly journals Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women With Prior Gestational Diabetes Mellitus

Diabetes Care ◽  
2004 ◽  
Vol 27 (7) ◽  
pp. 1721-1727 ◽  
Author(s):  
C. Winzer ◽  
O. Wagner ◽  
A. Festa ◽  
B. Schneider ◽  
M. Roden ◽  
...  
2003 ◽  
Vol 17 (2) ◽  
pp. 137-142 ◽  
Author(s):  
E. Akbay ◽  
M. B. Tıras ◽  
I. Yetkin ◽  
F. Törüner ◽  
R. Ersoy ◽  
...  

Diabetologia ◽  
2013 ◽  
Vol 56 (12) ◽  
pp. 2753-2760 ◽  
Author(s):  
Anny H. Xiang ◽  
Miwa Takayanagi ◽  
Mary Helen Black ◽  
Enrique Trigo ◽  
Jean M. Lawrence ◽  
...  

Diabetes Care ◽  
2016 ◽  
Vol 39 (6) ◽  
pp. 1052-1055 ◽  
Author(s):  
Camille E. Powe ◽  
Catherine Allard ◽  
Marie-Claude Battista ◽  
Myriam Doyon ◽  
Luigi Bouchard ◽  
...  

2004 ◽  
Vol 89 (5) ◽  
pp. 2306-2311 ◽  
Author(s):  
Michelle A. Williams ◽  
Chunfang Qiu ◽  
Martin Muy-Rivera ◽  
Surab Vadachkoria ◽  
Tara Song ◽  
...  

2015 ◽  
Vol 4 (3) ◽  
pp. 487-491
Author(s):  
Daniela Callegari ◽  
Carla Bresciani ◽  
Ezio Bianchi ◽  
Valeria De Cesaris ◽  
Enrico Parmigiani ◽  
...  

Gestational diabetes mellitus (GDM) is a rare disease in dogs that depends from an endogenous insulin supply that is insufficient to meet the tissues demands for the action of diabetogenic molecules like progesterone (P4), estradiol, growth hormone (GH), placental lactogen and placental cytokines. This report describes for the first time a case of GDM complicated by ketoacidosis treated with the P4 receptor blocker aglepristone. In our case aglepristone seemed to increase insulin sensitivity, helping in the resolution of ketoacidosis and of diabetes mellitus. Aglepristone may represent an effective and well tolerated therapeutic option in case of GDM.


Sign in / Sign up

Export Citation Format

Share Document